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Abstract. Expression of hepatocyte growth factor (HGF) and
its receptor, c-met is up-regulated in various forms of liver
injury. This study evaluated the relationship between HGF and
c-met expression and pathological changes in experimental
alcoholic liver disease. Rats (5 per group) were fed ethanol and
a diet containing saturated fat corn oil or fish oil by intragastric
infusion. Dextrose isocalorically replaced ethanol in controls.
In a second set of experiments, Kupffer cells, endothelial cells
and hepatocytes were isolated from rats in each group. Patho
logical evaluation and analysis of HGF and c-met expression
were performed in liver and the different cell types. Increased
expression of HGF and c-met expression was detected in the
liver of rats showing necroinflammatory changes. The Kupffer
and endothelial cells were primarily responsible for the
increase in HGF, c-met expression was seen only in hepato
cytes. Thus, up-regulation of HGF and c-met occurred in the
presence of the necrosis and inflammation suggesting that HGF
may be acting to protect against liver injury or accelerate the
regenerative process.
Introduction
H e p a t o c y t e growth factor (HGF) is the most powerful
hepatocyte mitogen in vitro (1) and it is also an extremely
potent mitogen, motogen, and morphogen in vivo (2-4). HGF
was first detected in the serum of both normal and partially
h e p a t e c t o m i s e d rats and was subsequently cloned and
sequenced by Nakamura et al (5). It has since been established
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that HGF is expressed by various mesenchymal-derived cells
throughout the body, but is produced in the liver by Kupffer,
endothelial and hepatic stellate cells (6). HGF produces its
biological effects by activating the transmembrane c-met
receptor (7-9), which on binding HGF, dimerises and cross
phosphorylates its intracellular tyrosine kinase sites, intiating
the signal transduction cascade which culminates in effecting
the mitogenic, motogenic and morphogenic properties of its
ligand (10). The exact mechanisms of these downstream effects
are not as yet fully elucidated.
The presence of necrosis and an inflammatory response
characterizes alcoholic liver disease (ALD). Since several lines
of investigation indicate that HGF is up-regulated in response
to hepatic injury (3), the aim of this study was to identify the
pattern of HGF and c-met expression in liver tissue and the
different cell types in alcohol-treated rats. We utilized the rat
model of intragastric feeding to induce alcoholic liver injury
(11,12) and to determine whether any such relationship might
exist between ALD and expression of HGF and c-met. This
strategy was employed primarily because the severity of injury
induced in the intragastric feeding model can be varied simply
by changing the type of dietary fat. For instance, based on
epidemiological studies relating to the nature of the dietary
fat and incidence of ALD (13) experimental studies have
demonstrated that rats fed saturated fatty acids and ethanol
develop none of the histological features of ALD (14) whereas
rats fed polyunsaturated fatty acids and ethanol show fatty
liver, necrosis, inflammation and fibrosis (15). Moreover, if
fish oil is fed with ethanol, the necrosis, inflammation and
fibrosis is much more severe than is seen in rats fed corn oil
and ethanol (16-18).
Thus, the ability to induce various grades of alcoholic liver
injury enabled us to relate the severity of liver damage to any
concomitant fluctuation in HGF or c-met expression between
the different dietary groups. Analysis of transcription of both
HGF and c-met genes was performed by in situ hybridization
(ISH) on formalin-fixed paraffin-embedded liver, in addition
to mRNA analysis by reverse transcription polymerase chain
reaction (RT-PCR) of liver tissue and purified parenchymal
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Table I. Blood alcohol levels (mean + SE) and pathological changes in the different experimental groups.
Experimental group
MCTD
MCTE
CD
CE
FD
FE

Blood alcohol (mg/dl)

Fatty liver (0-4)

Necrosis (foci/LPF)

Inflammation foci/LPF

0
242+47
0
249±37
0
244±45

0
0
0
3.4+0.5
0
4.0±0.0

0
0
0
l .2±0.4b
0
2.0±0.0a

0
0
0
1.2+0.4"
0
2.0+0.0"

a

p<0.05 vs. CE, p<0.01 vs MCTE; bp<0.01 vs MCTE. MCT, medium chain triglycerides; C, corn oil; F, fish oil; D, dextrose; E, ethanol.

and non-parenchymal liver cell populations obtained from the
rats in the different dietary groups.
Materials and methods
Animals. All animals used for this study were cared for in
accordance with the National Institutes of Health criteria for
care of laboratory animals. Six groups of male Wistar rats (five
rats per group) weighing 275-300 g were fed by continuous
infusion of a liquid diet via permanently implanted gastric
tubes, as previously described (11,12). The six diets were
constituted as follows: medium chain triglycerides, corn oil or
fish oil, each being supplemented with either dextrose
(MCTD,CD and FD) or ethanol (MCTE, CE and FE)
respectively. Dietary fatty acids contributed 35% of total
caloric intake and the fatty acid composition of these diets
has been described previously (17). Ethanol was initially
administered at a dose of 10 g/kg/day and was gradually
increased to 16 g/kg/day as tolerance developed. Blood alcohol
levels were maintained at between 150 and 300 mg/dl; blood
was collected from the tail vein and ethanol concentration
measured using an alcohol dehydrogenase assay (Sigma). All
rats were sacrificed four weeks after initiating each feeding
regime and the liver was processed as described below.
Isolation of hepatocytes, Kupffer cells and endothelial cells.
Detailed descriptions of the cell isolation and purification
procedures have already been published (19,30). Briefly, livers
were exsanguinated in situ, excised and finely minced and
incubated in 0.05% collagenase at 37°C for 45 min. Each of
the three cell populations were thereafter isolated and their
identities confirmed using, morphological criteria and immunohistochemical analyses (19). The purified cell populations were
stored at -70°C until required for RNA isolation and RT-PCR.
Analysis of HGF, c-met and fJ-actin expression in whole tissue
and cells by RT-PCR. Total RNA was isolated from both
whole liver tissue and the purified cell populations according
to the guanidium isothiocyanate method (8). The integrity of
isolated RNA was determined by agarose gel electophoresis
and ethidium bromide staining. Total RNA (0.5-1.0 |ig) was
reverse transcribed and the resultant HGF, c-met and B-actin
cDNAs were amplified using the conditions described
previously (19). The sequences of the primers used in this

study have been previously published (20,21). Negative
controls for each experiment consisted of analyzing a
sample of total RNA which had not undergone reverse
transcription.
PCR products and appropriate molecular weight markers
were electrophoresed on a 1 % agarose gel and after staining
with ethidium bromide were analysed by laser scanning
densitometry (Molecular Dynamics, Sunnyvale, CA). None of
the negative control samples yielded any product, confirming
the absence of contaminating DNA species.
Histopathological analysis. Small samples of exsanguinated
livers were fixed overnight in formalin, routinely processed
and embedded in paraffin wax. Five micron sections were cut
from these blocks, processed for routine haematoxylin and
eosin (H&E) staining and the severity of pathological
changes (i.e. extent of steatosis, necrosis and inflammation)
were ascertained as previously described (14,18). Briefly the
degree of steatosis was graded according to the percentage
of liver cells containing fat and necrosis and inflammation
according the number of foci per power field.
In situ hybridization for HGF and c-met mRNAs. The method
described is based on that by Senior et al (22) with slight
modifications (23). Each sample was prepared in duplicate so
that two exposure times to the emulsion (14 and 28 days) could
be performed. Plasmids containing cDNA for regions of rat
HGF (rHGF) (Eco RI subclone from RBC1 in pBluescript SK
vector) were kindly provided by Dr T. Nakamura, Kyushu
University, Fukuoka, Japan; the mouse c-met (SphI - Sad
subclone into Bluescribe), was kindly provided by Dr Laki
Buluwela, Charing Cross & Westminster Medical School,
London, UK; and the rat 6-actin control was produced and
provided by Dr Rebecca Chinery, ICRF Histopathology Unit,
London, UK. These plasmids were used to produce antisense
riboprobes internally labeled with approximately 800 Ci/mmol
of (24) serum.
The rHGF probe of approximately 1.4 kb was generated
from Eco RV restriction enzyme linearised plasmid; mouse
c-met probe of 0.79 kb was generated from Hindlll linearised
plasmid, and rat B-actin probe of 0.24 kb was generated from
Eco RI restriction enzyme linearised plasmid. The probes were
transcribed using T3 (rHGF and B-actin) or T7 (c-met) RNA
polymerases (Promega). In vitro transcription using 0.5 mg
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Figure 2. Densitometric analysis for c-met mRNA normalized using B-actin in
(A) liver and (B) hepatocytes in the different treatment groups. Ethanol
administration led to significant increases (p<0.01) in c-met mRNA in the liver
and hepatocytes in the corn oil-ethanol and fish oil-ethanol group, c-met
mRNA was not detected in Kupffer and endothelial cells. *p<0.01 vs.
dextrose fed groups and MCTE.

Figure 1. Densitometric analysis for HGF mRNA normalized using 13-actin in
(A) livers, (B) endothelial cells and (C) Kupffer cells in the different treatment
groups. Ethanol administration led to significant increases (p<0.01) in HGF
mRNA in the liver, endothelial cells and Kupffer cells in the corn oil and
fish oil groups but not in the MCT group. HGF mRNA was not detected in
hepatocytes. *p<0.05 vs. MCTD, MCTE, CD; *p<0.05 vs. all other groups.

counterstained with 1% v/v Giemsa solution, air-dried and
mounted in Pertex. Patterns of hybridization was studied under
both light-field and dark-field (reflected light) conditions.
Statistical analysis. All data are expressed as means + SD
unless stated otherwise. Differences between the groups were
analyzed using analysis of variance with post hoc analysis
using the Bonferroni test.
Results

of probe template, 5U RNA polymerase per mg of template,
1 mM each of ATP, GTP, CTP and 14 mM of 35S-UTP
(Amersham) was carried out for 1 h at 37°C. The probe
template was then destroyed by incubation for 15 min at 37°C
with 1ml of RNAse-free DNAse I (Boehringer) and the
labeled probe then purified using a Chromaspin-30 column
(Clontech Laboratories).
Sections (4 mm thick) of formalin fixed, paraffin embedded
livers were de-waxed, hydrated through DEPC-treated graded
ethanol and washed in PBS. Sections were then permeabilised
at 37°C with 20 mg/ml Proteinase K in PBS for 10 min, rinsed
in PBS and post-fixed for 20 min in 4% w/v paraformaldehyde
in PBS. Sections were then rinsed briefly in three changes of
PBS, dehydrated through graded ethanols and air-dried.
The sections were then hybridized overnight at 55°C and
processed through post hybridization and stringency washes
as previously described (23). Autoradiography was carried out
using standard procedures and the sections were subsequently

Weight gain, blood alcohol levels and histopathology. All of
the rats gained weight over the experimental period and no
significant difference in weight gain was detected between
the ethanol-treated and control groups, nor was there any
significant difference in the mean blood alcohol levels in the
ethanol treated rats (Table I).
As previously observed (19), no pathological changes were
seen in either the dextrose-fed control groups (MCTD, FD and
CD) or in those animals receiving medium chain triglycerides
and ethanol (MCTE). Injury was detected in corn oil and fish
oil, ethanol-fed animals with the pathological profile being
more severe in those rats which had received fish oil and
ethanol (FE) (Table I).
Expression of HGF and c-met mRNAs. The relative abundance
and cellular origin of HGF and c-met transcripts were
examined by RT-PCR analysis of whole liver homogenates

814

LALANI et al: EXPRESSION OF HGF AND c-met IN LIVER INJURY

Figure 3. In situ hybridization for HGF in a liver from a rat on a fish oil ethanol (FE) diet showing scattered HGF labeling of cells adjacent to the sinusoids,
but not hepatocytes. Original magnification x250.

and purified populations of hepatocytes, endothelial cells and
Kupffer cells. Fig. 1 displays the relative abundance of HGF
mRNA in whole liver and demonstrates that HGF expression
increased significantly only in rats fed ethanol in combination
with either fish oil or corn oil. The FE diet was clearly the most
significant inducer of HGF expression. Moreover, similar
analyses of c-met expression showed an identical pattern with
significant increases in the CE and FE groups and the largest
increase was in the FE group (Fig. 2).
These observations in whole liver are further supported by
the RT-PCR results pertaining to the purified cell populations
(Figs. 1 and 2), which clearly demonstrates that HGF is
expressed by the endothelial and Kupffer cells. As was seen
with whole liver, the level of expression in both cell types was
highest in the FE treated livers. Expression of c-met on the
other hand was confined only to hepatocytes which had been
isolated from ethanol fed rats (Fig. 2). Of note is that both
HGF and c-met mRNAs were detected in all of the whole liver
homogenates, yet neither mRNA species was detectable in
any of the purified cell populations isolated from those rats
receiving the dextrose containing diets. This apparent anomaly
can, however, be explained by the fact that HGF and c-met
transcripts are expressed in normal liver principally by the
stellate (Ito) cells (14) and cholangiocytes (15) respectively,
cell types which had not been purified in this study.
In situ hybridization for HGF confirmed the results
obtained by RT-PCR analysis and revealed that in animals
fed ethanol in combination with either fish oil or corn oil, there
was strong labeling for HGF of non-hepatocyte cells scattered
in the parenchyma (Fig. 3). Higher power fields revealed that
these cells were adjacent to the sinusoids, in a distribution
consistent with Kupffer and sinusoidal endothelial cells,

although there were identifiable unlabelled sinusoidal
endothelial cells (Fig. 4).
c-met expression was only consistently detected in the
same groups of animals in which HGF was demonstrable by
ISH (FE and CE) (Fig. 5). Livers from animals in both these
groups showed c-met labeling predominantly over hepatocytes
with no enhancement of labeling of sinusoidal lining cells.
There was very little background labeling. There was no
labeling for c-met in the dextrose-fed groups or rats fed ethanol
with medium chain triglycerides (data not shown).
Discussion
HGF was originally discovered to be a potent mitogenic
factor for hepatocytes, and it is known to additionally possess
a multitude of functions, inducing mitogenic, motogenic,
morphogenic and tumoricidal effects upon a variety of cell
types. HGF transduces these multiple biologic effects via
activation of the transmembrane tyrosine kinase c-met receptor
(7-9). In the liver, c-met is only expressed in hepatocytes and
cholangiocytes, while HGF expression is restricted to the
mesenchymal cells, primarily the stellate, Kupffer and endo
thelial cell populations (25,26).
The important finding in this study was that HGF gene
expression was up-regulated in ethanol-fed rats, which develop
liver injury. Furthermore, RT-PCR analysis of purified cell
populations confirmed that the Kupffer and endothelial cells
were responsible for this increased HGF expression. Although
there are criticisms of PCR-based approaches to the
quantitation of specific mRNAs, our results by RT-PCR are
supported by in situ hybridization studies on liver tissue. The
hepatocytes concomitantly up-regulated c-met expression,
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Figure 4. A higher power view of the same liver as Fig. 3 shows strong labeling for HGF (>100 grains/cell) ol' sinusoidal and endothelial cells. Original
magnification x400.

Figure 5. In situ hybridization for c-met in a liver from a rat fed corn oil ethanol (CE) showing fatty change and c-met labeling predominantly over
hepatocytes with no enhancement of labeling of sinusoidal lining cells and little background labeling. The central vein is seen at the top right of the field.
Original magnification x400.

suggesting the possibility that increased c-met was responsive
to the increased levels of HGF.
Studies using other models of liver injury have also shown
HGF expression to be up-regulated in both Kupffer and
endothelial cells (27,28). For example, carbon tetrachloride

administration stimulates a dramatic increase in HGF
expression by endothelial cells but not in Kupffer or stellate
cells (29). However, the present study showed that both
endothelial and Kupffer cells (stellate cells were not isolated)
up-regulated HGF expression in this model, an inconsistency
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possibly related to the different time scales of the two studies.
For instance, Maher sampled livers between 2 and 48 h after
administration of the hepatotoxin (29), whereas our study
analysed cells one month after ethanol administration. It is
therefore possible that HGF expression by specific cell types
after injury is sequential, and thus time-dependent, and/or is
governed by the experimental model employed.
The exact mechanism(s) leading to hepatic HGF upregulation in ethanol-fed rats is unknown, although increased
expression of this growth factor is a phenomenon commonly
associated with liver damage. For example, HGF expression
increases dramatically in Long Evans Cinnamon rats which
develop fulminant hepatitis (30), and similary in rats after
galactosamine or carbon tetrachloride poisoning where the
extent of liver damage has been shown to correlate directly
with the level of HGF expression (29-31). It has also been
demonstrated that the production of HGF activator, a serine
protease, is increased in response to tissue injury as a result
of an inflammatory response. HGF activator is responsible for
localized activation of H G F in injured tissue (32). The
discovery that transcription of the HGF and c-met genes is
promoted in stromal and epithelial cells respectively, by
inflammatory cytokines such as TNF-a and IL-1, supports the
notion that both HGF and its receptor are involved, at least in
part, in the mediation of inflammatory responses associated
with liver injury (33). TNF-a and IL-1 levels are increased
during ALD in man (34,35) and TNF-a mRNA expression also
is increased in the livers of rats receiving unsaturated fatty
acids and ethanol (36).
In addition to its described hepatotrophic and biological
activities, HGF may also have a cytoprotective role to play
during a hepatotoxic insult. For example, HGF antagonizes
interferon-y-induced h e p a t o t o x i c i t y in cultured m o u s e
hepatocytes (37), and an in vitro study has shown that HGF
antagonizes the effects of IL-6 in inducing acute phase
proteins in the liver (38). Similar effects have also been noted
in vivo; a continuous supply of circulatory HGF produced by
intrasplenically transplanted fibroblasts prevents carbon
tetrachloride-induced liver damage in rats (39) and intra
venous injections of recombinant human HGF suppress the
progression of dimethylnitrosamine-induced hepatic injury and
fibrosis (27). HGF also protects against liver injury caused by
galactosamine and lipopolysaccharide (24,40). Although the
exact mechanism for the protective effect of HGF is unknown,
HGF increases glutathione in the liver (41) and also inhibits
hepatocyle apoptosis (42).
The increased expression of c-met in hepatocytes of
ethanol-fed rats is likely to be secondary to increased HGF
production (43). HGF increases the expression of c-met which
consequently amplifies the stimulus and, therefore, response of
its target cells (43). Indeed, such an augmented response has
also been observed in the regenerating livers of rats treated
with carbon tetrachloride (44).
Overall, our results show that up-regulation of HGF and its
receptor c-met, is most prominent in rats developing the most
severe injury. Although the casual relationships between
HGF and c-met expression and liver injury are uncertain, we
can speculate however, that HGF may be acting to protect the
liver from further damage (45). Additionally, H G F may
accelerate the regenerative process, a view supported by

others (12,46). We should, however, point out that the degree
of cell regen-eration was not evaluated in the present study
but other investigators have shown that hepatic regeneration
occurs in rats fed unsaturated fatty acids and ethanol (47).
Clearly, HGF is not the only mediator of such responses, as
several factors have been implicated to be of importance in
alcoholic liver injury. Thus, the complexity of the multitude
of interactions taking place between these molecules must be
taken into account. Hepatocyle growth factor is only one of
the many mediators which regulate the liver's response to
a l c o h o l i c insult, and thus its interplay with the other
regenerative factors is a particularly important area for
continued investigation.
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